What is a clinical trial?
Significant advances in cancer research and treatments are being made all the time. Yet, it takes many months, and sometimes years, for these treatments to become approved and enter the market. This is because rigorous research and testing in clinical trials is required before a treatment becomes accepted. All current FDA-approved treatments were first tested in clinical trials long before they were approved and made available to the general public.
How do I find out about clinical trials?
Am I eligible for a clinical trial?
How can I obtain more information on clinical trials and research taking place in your office?
For more information on clinical trials and research at Island Gynecologic Oncology, please contact a member of our clinical research team at (631) 376-0055 ext. 107.
Current Clinical Trials and Research
CARIS Registry Target Now - Biomarker Expression Patterns and Hematopoietic Diagnostics for Evaluation of Correlation with Clinical Outcomes for Cancer and other Patients
Sera Trials Bioreclamation – Specimen studies of women with Ovarian, Cervical, or Endometrial Cancer
FIGO DATA COLLECTION PROGRAM
S1316 SWOG - This partially randomized clinical trial studies surgery or non-surgical management in treating patients with intra-abdominal cancer and bowel obstruction. Bowel obstruction is a common problem for advanced cancer patients and can negatively affect quality of life. It is not yet known whether surgery or non-surgical management is the best treatment option for bowel obstruction and can lead to better quality of life.
NRG-CC004 - This phase II randomized trial studies how well bupropion hydrochloride works in improving sexual desire in women with breast or gynecological cancer. Bupropion hydrochloride may work by boosting sexual desire, energy, or motivation without causing intolerable or undesirable side effects.
MD Anderson Conserv trial - The goal of this surgical research study is to learn if "conservative surgery" is a safe and feasible option for women with low-risk cervical cancer (stage IA2 or IB1, Grade 1 or 2).